PRESS RELEASE

FOR IMMEDIATE RELEASE

Media contact

Dennis Joseph
Buds Technology
+1 (614) 668 8845 | dennis@budstechnology.com
akssi.com | info@budstechnology.com

Buds Technology launches
Akssi™ Eligibility-Assist

Data-driven tool reduces hospice denials, speeds
reviews and strengthens compliance

Atlanta, GA, October 21, 2025

Buds Technology today launched Akssi™ Eligibility-Assist, a data-driven automation tool that helps hospices reduce denials, strengthen compliance and support clinicians with clear, defensible documentation. Eligibility-Assist applies Centers for Medicare & Medicaid Services eligibility logic to structured and unstructured clinical data and produces physician-ready analyses and summaries. It surfaces key indicators in the context of each patient's diagnosis profile.

"In an environment where audit pressure is intensifying, hospices need more than intuition; they need rigor," said Farrokh Abadi, CEO of Buds Technology.

"Eligibility-Assist gives care teams confidence that their narratives are backed by referenceable, measurable observations rather than vague prose."

Why this matters now

Recent Medicare review data shows a large share of hospice denials stem from insufficient documentation supporting a six-month or less terminal prognosis (denial reason 5PM01). CGS Medicare

In a national hospice audit survey, more than half of reported denials cited the same 5PM01 reason. National Alliance for Care at Home

How Eligibility-Assist works

Eligibility-Assist translates regulatory rules, such as local coverage determinations, into decision-tree logic and evaluates trends in activities of daily living, Palliative Performance Scale scores, weight, pain, hospitalizations, comorbidities and medications. It generates an eligibility summary for the current benefit period and links findings to source documentation, including skilled nursing notes, medication records and lab results. Physicians can edit the summary, and the interdisciplinary team finalizes the determination.

Key benefits

Reduce denials:
Capture objective, quantifiable measures supporting six-month prognosis determinations

Save time:
Automate reviews that otherwise require hours of manual chart work

Strengthen compliance:
Produce consistent, defensible, audit-ready documentation

Empower clinicians:
Deliver transparent, data-backed narratives with source references

Align the care team:
Provide a single, comprehensive patient summary to keep the team aligned

"Reviews that used to take hours now can happen in minutes, with clear, defensible documentation every time," said Amanda McKissick, CEO of Blue Summit Hospice and Palliative Care.

Initial pilots report sharp reductions in manual review time and tighter narrative coherence. Buds Technology plans a nationwide rollout of Eligibility-Assist to hospice clients this quarter.

About Akssi™ and Buds Technology

Akssi™ is a compliance-first, AI-enabled SaaS platform built for hospice operations. Modules include Workflow-Automation, Audit-Scan, Lighthouse-Navigate, Symptom Tracker and Eligibility-Assist. The platform is designed to help providers grow revenue, maintain compliance and improve care.

For more information, visit
www.akssi.com